Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
AOD9604 is bioavailable orally, with MS peptide analysis confirming appearance in pig plasma following oral dosing, and degradation occurring primarily via sequential N-terminal amino acid removal in a cascade fashion
Cagrilintide monotherapy weight loss In the phase 2 trial over 26 weeks, cagrilintide weight loss ranged from 6.0% to 10.8% of body weight depending on dose
gave me peace of mind
What sets us apart: Fermentation-derived L-glutathione (reduced form) - clean-label compliant 98% purity - HPLC-verified per batch Full stability documentation - nitrogen-flushed, moisture-barrier packaging Complete contaminant panel - heavy metals, microbials, residual solvents Flexible MOQs - from R&D quantities to full commercial scale Custom specifications - particle size, bulk density, water activity Formulation support - synergistic stack recommendations for thyroid, immune, and detox applications Full regulatory documentation for global market submissions 11
